Earnings call transcript: Piper Sandler Q4 2024 beats estimates, stock rises
Piper Sandler Companies reported robust fourth-quarter 2024 earnings, with earnings per share (EPS) of $4.8, surpassing the forecast of $3.93. The company's revenue reached $499 million, exceeding ...
Piper Sandler maintains Pepsico stock Overweight with $171 target
Piper Sandler maintained an Overweight rating on Pepsico (NASDAQ:PEP) stock with a steady price target of $171.00. The ...
Zacks.com on MSN2h
Piper Sandler Companies (PIPR) Q4 Earnings and Revenues Beat Estimates
Piper Sandler Companies (PIPR) delivered earnings and revenue surprises of 32.60% and 14.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...
Higher cocoa prices will pressure Hershey’s stock, analyst says
Piper Sandler downgrades Hershey Co. to underweight from neutral on expectation of stubbornly high cocoa prices.
Piper Sandler Sees Buying Opportunity as Bitcoin Miners Extend Losses
Bitcoin mining stocks drop further despite Piper Sandler's bullish outlook on AI-driven infrastructure expansion and crypto ...
Microsoft's AI Revenue Set To Surpass $10 Billion: Piper Sandler Maintains Overweight Rating
Microsoft Corporation's cloud computing platform, Azure's workloads could push its artificial intelligence revenue to $10 ...
Piper Sandler维持百事可乐股票"增持"评级，目标价171美元
周五，Piper Sandler维持了对百事可乐股票的"增持"评级，目标价保持在171.00美元不变。该研究公司的关注点集中在公司2025年的潜在反弹上，特别是通过其Doritos品牌。根据 InvestingPro ...
Piper Sandler Reaffirms Their Sell Rating on Ameriprise Financial (AMP)
In a report released today, John Barnidge from Piper Sandler maintained a Sell rating on Ameriprise Financial (AMP – Research Report), with a ...
Piper Sandler Reaffirms Their Hold Rating on Hope Bancorp (HOPE)
Piper Sandler analyst Matthew Clark maintained a Hold rating on Hope Bancorp (HOPE – Research Report) today and set a price target of $12.00.
F5 Sees Big Wins in Multi-Cloud, AI Security, and IT Refresh, Analysts Forecast More Upside
F5 Inc (NASDAQ:FFIV) stock is trading higher Wednesday after the company reported better-than-expected first-quarter ...
Piper Sandler将ResMed股票目标价上调至260美元
周五，Piper Sandler分析师Adam Maeder将ResMed（NYSE:RMD）的目标价从252美元上调至260美元，同时维持对该股的中性评级。目前，ResMed股价交易于257.65美元，接近其52周高点263.05美元，显示出强劲势头，过去一年回报率达36.7%。此次调整是在ResMed发布财政第二季度业绩后做出的，该业绩在收入和每股收益（EPS）方面均超过了市场预期。